January 11, 2023

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

LONDON AND HONG KONG, Jan 11, 2023 – (ACN Newswire via SEAPRWire.com) – Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing,…

January 9, 2023

Malaysian Genomics Explores R&D Collaboration with SIRIM

PETALING JAYA, Malaysia, Jan 9, 2023 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical…

December 16, 2022

Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics

HONG KONG, Dec 16, 2022 – (ACN Newswire via SEAPRWire.com) – Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic…

November 23, 2022

Malaysian Genomics Sees Rise in Profit Margins for 1Q

PETALING JAYA, Malaysia, Nov 23, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today reported…

October 26, 2022

Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE

United Arab Emirates (UAE), Oct 26, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and…

October 12, 2022

Malaysian Genomics Signs Agreement with National Institutes of Health to Explore Research Opportunities

PETALING JAYA, Malaysia, Oct 12, 2022 – (ACN Newswire via SEAPRWire.com) – MGRC Therapeutics Sdn Bhd (MGRC-T), a wholly-owned subsidiary of Malaysian Genomics Resource Centre…

September 23, 2022

Malaysian Genomics Grows Presence in Thailand

PETALING JAYA, Malaysia, Sep 23, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical…

September 21, 2022

Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah

PETALING JAYA, Malaysia, Sep 21, 2022 – (ACN Newswire via SEAPRWire.com) – Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155)…

August 30, 2022

Malaysian Genomics Reports RM28.36 Million Full-Year Revenue

PETALING JAYA, Malaysia, Aug 30, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue…

August 29, 2022

Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region

PETALING JAYA, Malaysia, Aug 29, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical…

July 20, 2022

UCrest Partners with Malaysian Genomics to Digitalize Genome Services Worldwide

PETALING JAYA, Malaysia, Jul 20, 2022 – (ACN Newswire via SEAPRWire.com) – UCrest Berhad (ACE Market: 0005) and Malaysian Genomics Resources Centre Berhad, (ACE Market:…

July 15, 2022

Malaysian Genomics Appoints New Chairman

PETALING JAYA, Malaysia, Jul 15, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical…

July 13, 2022

Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia

PETALING JAYA, Malaysia, Jul 13, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical…

July 8, 2022

Malaysian Genomics Proposes Private Placement

PETALING JAYA, Malaysia, Jul 8, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical…

June 23, 2022

Malaysian Genomics Resource Centre to Offer Pioneering Holistic Renal Care via New Venture

PETALING JAYA, Malaysia, Jun 23, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical…

June 13, 2022

Malaysian Genomics Resource Centre Berhad Gets Affected Issuer Status Uplifted

PETALING JAYA, Malaysia, Jun 13, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical…

May 23, 2022

Malaysian Genomics Resource Centre Berhad Posts 212% Increase in Revenue for 3Q FY2022

PETALING JAYA, Malaysia, May 23, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced…

April 28, 2022

Malaysian Genomics Resource Centre Berhad Supports Yayasan Seri Negara’s Ramadhan Initiative

PETALING JAYA, Malaysia, Apr 28, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical…

April 4, 2022

Malaysian Genomics Resource Centre Berhad Awarded Covid-19 Surveillance Contract

PETALING JAYA, Malaysia, Apr 4, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (“Malaysian Genomics” or “the Group”), a leading genomics…

November 22, 2021

ACT Genomics and Sanomics Merge to Unleash Hong Kong’s Global Potential in Healthcare Technology

HONG KONG, Nov 22, 2021 – (ACN Newswire via SEAPRWire.com) – ACT Genomics Holdings Co. Ltd. (“ACT Genomics” or “the Group”) a leading cancer solution…